Nektar
IPOBold immune science. Transformative immune health.
San Francisco, United States · Founded 1990
- Headquarters
- San Francisco, California
- Employees
- 201–500
- Founded
- 1990
- Business Model
- B2B
About
Nektar Therapeutics is a biopharmaceutical company focused on bold immune science and transformative immune health. The company is steadfast in its efforts to develop novel medicines that redefine treatment paradigms for autoimmune and inflammatory conditions, resolving immune imbalances to regain immune homeostasis. Nektar rapidly advances first-in-class therapeutic candidates with disease-modifying potential and has a strong track record of partnering, contributing to numerous commercially approved medicines.
Summary
Nektar is a Biotech company based in San Francisco, United States, founded in 1990.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...